These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33187540)

  • 21. Conformational features and binding affinities to Cripto, ALK7 and ALK4 of Nodal synthetic fragments.
    Calvanese L; Sandomenico A; Caporale A; Focà A; Focà G; D'Auria G; Falcigno L; Ruvo M
    J Pept Sci; 2015 Apr; 21(4):283-93. PubMed ID: 25588905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Novel Inhibitor of Carbonic Anhydrases Prevents Hypoxia-Induced TNBC Cell Plasticity.
    Sarnella A; D'Avino G; Hill BS; Alterio V; Winum JY; Supuran CT; De Simone G; Zannetti A
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33182416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis.
    Strizzi L; Bianco C; Normanno N; Salomon D
    Oncogene; 2005 Aug; 24(37):5731-41. PubMed ID: 16123806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection and localization of Cripto-1 binding in mouse mammary epithelial cells and in the mouse mammary gland using an immunoglobulin-cripto-1 fusion protein.
    Bianco C; Normanno N; De Luca A; Maiello MR; Wechselberger C; Sun Y; Khan N; Adkins H; Sanicola M; Vonderhaar B; Cohen B; Seno M; Salomon D
    J Cell Physiol; 2002 Jan; 190(1):74-82. PubMed ID: 11807813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of CEP-37440, an inhibitor of focal adhesion kinase, in vitro and in vivo on inflammatory breast cancer cells.
    Salem I; Alsalahi M; Chervoneva I; Aburto LD; Addya S; Ott GR; Ruggeri BA; Cristofanilli M; Fernandez SV
    Breast Cancer Res; 2016 Mar; 18(1):37. PubMed ID: 27009091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Nodal- and ALK4-independent signaling pathway activated by Cripto-1 through Glypican-1 and c-Src.
    Bianco C; Strizzi L; Rehman A; Normanno N; Wechselberger C; Sun Y; Khan N; Hirota M; Adkins H; Williams K; Margolis RU; Sanicola M; Salomon DS
    Cancer Res; 2003 Mar; 63(6):1192-7. PubMed ID: 12649175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The CRIPTO/FRL-1/CRYPTIC (CFC) domain of human Cripto. Functional and structural insights through disulfide structure analysis.
    Foley SF; van Vlijmen HW; Boynton RE; Adkins HB; Cheung AE; Singh J; Sanicola M; Young CN; Wen D
    Eur J Biochem; 2003 Sep; 270(17):3610-8. PubMed ID: 12919325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EGFR inhibition blocks cancer stem cell clustering and lung metastasis of triple negative breast cancer.
    Liu X; Adorno-Cruz V; Chang YF; Jia Y; Kawaguchi M; Dashzeveg NK; Taftaf R; Ramos EK; Schuster EJ; El-Shennawy L; Patel D; Zhang Y; Cristofanilli M; Liu H
    Theranostics; 2021; 11(13):6632-6643. PubMed ID: 33995681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nodal signals to Smads through Cripto-dependent and Cripto-independent mechanisms.
    Yeo C; Whitman M
    Mol Cell; 2001 May; 7(5):949-57. PubMed ID: 11389842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of Cripto-1 during epithelial-to-mesenchymal transition in development and cancer.
    Rangel MC; Karasawa H; Castro NP; Nagaoka T; Salomon DS; Bianco C
    Am J Pathol; 2012 Jun; 180(6):2188-200. PubMed ID: 22542493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cripto promotes A-P axis specification independently of its stimulatory effect on Nodal autoinduction.
    D'Andrea D; Liguori GL; Le Good JA; Lonardo E; Andersson O; Constam DB; Persico MG; Minchiotti G
    J Cell Biol; 2008 Feb; 180(3):597-605. PubMed ID: 18268105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. KR-33028, a potent inhibitor of the Na
    Amith SR; Wilkinson JM; Fliegel L
    Biochem Pharmacol; 2016 Oct; 118():31-39. PubMed ID: 27521504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cripto-1 as a Key Factor in Tumor Progression, Epithelial to Mesenchymal Transition and Cancer Stem Cells.
    Arnouk H; Yum G; Shah D
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fangjihuangqi Decoction inhibits MDA-MB-231 cell invasion in vitro and decreases tumor growth and metastasis in triple-negative breast cancer xenografts tumor zebrafish model.
    Guo Y; Fan Y; Pei X
    Cancer Med; 2020 Apr; 9(7):2564-2578. PubMed ID: 32037729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-3929 Inhibits Proliferation and Promotes Apoptosis by Downregulating Cripto-1 Expression in Cervical Cancer Cells.
    Wang Y; Li X; Wang S; Song Z; Bao Y; Zheng L; Wang G; Sun Y
    Cytogenet Genome Res; 2021; 161(8-9):425-436. PubMed ID: 34569498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The bromodomain inhibitor OTX015 (MK-8628) exerts anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus.
    Vázquez R; Riveiro ME; Astorgues-Xerri L; Odore E; Rezai K; Erba E; Panini N; Rinaldi A; Kwee I; Beltrame L; Bekradda M; Cvitkovic E; Bertoni F; Frapolli R; D'Incalci M
    Oncotarget; 2017 Jan; 8(5):7598-7613. PubMed ID: 27935867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blockade of Cripto binding to cell surface GRP78 inhibits oncogenic Cripto signaling via MAPK/PI3K and Smad2/3 pathways.
    Kelber JA; Panopoulos AD; Shani G; Booker EC; Belmonte JC; Vale WW; Gray PC
    Oncogene; 2009 Jun; 28(24):2324-36. PubMed ID: 19421146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Embryonic stem cell secreted factors decrease invasiveness of triple-negative breast cancer cells through regulome modulation.
    Tarasewicz E; Oakes RS; Aviles MO; Straehla J; Chilton KM; Decker JT; Wu J; Shea LD; Jeruss JS
    Cancer Biol Ther; 2018 Apr; 19(4):271-281. PubMed ID: 29053396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Cripto-1 in stem cell maintenance and malignant progression.
    Bianco C; Rangel MC; Castro NP; Nagaoka T; Rollman K; Gonzales M; Salomon DS
    Am J Pathol; 2010 Aug; 177(2):532-40. PubMed ID: 20616345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer.
    Granados-Principal S; Liu Y; Guevara ML; Blanco E; Choi DS; Qian W; Patel T; Rodriguez AA; Cusimano J; Weiss HL; Zhao H; Landis MD; Dave B; Gross SS; Chang JC
    Breast Cancer Res; 2015 Feb; 17(1):25. PubMed ID: 25849745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.